In an announcement made on Thursday, Toyota revealed that it is recalling 430,500 more vehicles because of three separate safety issues. The vehicles being recalled by Toyota include 370,000 Sienna minivans from the 2004 through 2011 model years; 50,000 Highlander and Highlander hybrid SUVs from the 2014 model year; and 10,500 Lexus GS 350 sedans from the 2013 model year.
About the safety issues which have prompted the recall of the mentioned vehicles Toyota said that the Sienna minivans are being recalled in cold weather states, as the spare tire carrier under the vehicle can get corroded due to road salt, and can cause the tire to fall off.
In connection with the problem affecting the recalled Highlander and Highlander hybrid SUVs, Toyota said that vehicles apparently fail to make a proper calculation of the size of the front passenger while determining the deployment of the air bag.
Meanwhile, the problem with the recall-affected Lexus GS 350 sedans is that the brakes of these vehicles can get activated without warning.
Toyota has asserted that the defects in the recalled vehicles have not caused any accidents or injuries; and said that the affected vehicles will be repaired by the dealers for free.
According to a deal announced by Microsoft, the company’s online store is offering a markdown on the Lumia 550 smartphone. The handset, which was originally priced at $139, is being sold by the Microsoft online store for $99 unlocked.
As...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
According to a deal announced by Microsoft, the company’...
In a series of Twitter posts released on Sunday, Elon...
In a recently published blog post, "social media...
With tech giant Google scheduled to launch the Play...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).